Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

51.56

-0.48 (-0.92%)

Nov 12, 2026, 4:00 PM EST - Market closed

Travere Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	651.03	490.73	233.18	145.24	109.46	131.84
Revenue Growth	49.38%	110.45%	60.55%	32.69%	-16.97%	-33.52%
Gross Profit	397.56	274.38	7.94	-111.2	-122.29	-73.14
Operating Income	-20.38	-62.82	-256.18	-376.74	-319.81	-199.43
Net Income	-121.51	-25.55	-321.55	-111.4	-278.48	-180.09
Earnings Per Share	-1.31	-0.29	-4.08	-1.50	-4.37	-3.01
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	471.82	322.8	370.7	566.85	450.25	552.88
Total Debt	616.16	328.73	401.58	404.78	407.49	261.99
Net Cash (Debt)	-144.34	-5.94	-30.88	162.07	42.76	290.9
Net Cash Growth	-	-	-	279.04%	-85.30%	147.45%
Net Cash Per Share	-1.56	-0.07	-0.39	2.18	0.67	4.86

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	176.59	37.78	-237.48	-280.02	-186.29	-14.79
Capital Expenditures	0.38	-	-	-	-	-5.1
Free Cash Flow	176.96	37.78	-237.48	-280.02	-186.29	-19.89
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	61.07%	55.91%	3.40%	-76.57%	-111.72%	-55.48%
Operating Margin	-3.13%	-12.80%	-109.87%	-259.40%	-292.17%	-151.27%
Pretax Margin	-24.53%	-10.04%	-137.45%	-258.96%	-302.54%	-164.51%
Profit Margin	-18.66%	-5.21%	-137.90%	-76.70%	-254.41%	-136.60%
FCF Margin	27.18%	7.70%	-101.84%	-192.80%	-170.19%	-15.09%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	10.95	38.08	42.85	42.85	42.85	42.85
P/FCF Ratio	27.97	90.48	-	-	-	-
PS Ratio	7.60	6.97	6.50	4.65	12.33	14.42